TMP778, a selective inhibitor of RORγt, suppresses experimental autoimmune uveitis development, but affects both Th17 and Th1 cell populations

Abstract excerpt

Experimental autoimmune uveitis (EAU), an animal model for severe intraocular inflammatory eye diseases, is mediated by both Th1 and Th17 cells. Here, we examined the capacity of TMP778, a selective inhibitor of RORγt, to inhibit the development of EAU, as well as the related immune responses. EAU was induced in B10.A mice by immunization with interphotoreceptor retinoid-binding protein (IRBP). Treatment with...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to NF-κB Signaling Pathways
• Share to Ocular Diseases and Behçet’s Syndrome
• Share to Psoriasis: Treatment and Pathogenesis